Ondansetron Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2 mg/2 mL, 4 mg/2 mL , 8 mg/4 mL

Reference Brands: Zofran(US & EU)

Category: Oncology Cancer Care

Ondansetron Injection (2 mg/2 mL, 4 mg/2 mL, 8 mg/4 mL) is used in oncology to prevent chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and vomiting (RINV). Available in both U.S. and EU, this 5-HT3 receptor antagonist is administered via IV injection. Ondansetron effectively blocks serotonin to reduce nausea and vomiting, improving patient comfort during cancer treatments. It's a key product in oncology B2B distribution, ensuring better quality of care for patients undergoing chemotherapy and radiation therapy. Ondansetron Injection is available in Injection and strengths such as 2 mg/2 mL, 4 mg/2 mL , 8 mg/4 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ondansetron Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ondansetron Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Ondansetron Injection 2 mg/2 mL, 4 mg/2 mL, and 8 mg/4 mL is an essential medication in oncology for the prevention of chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and vomiting (RINV). As a 5-HT3 receptor antagonist, it effectively blocks serotonin, reducing nausea and vomiting associated with highly emetogenic chemotherapy. Ondansetron is available in IV solution form and is widely used in oncology B2B distribution across the U.S. and EU. It plays a vital role in improving patient comfort during cancer treatment.